capital raising expectations, page-30

I reckon PoH will be cash flow positive in about 12 months provided Cellucreme works well. Also depending on what is done with Oxypatch.

My feeling is from what POH have stated is the idea is to get oxypatch trials moving from this soon to be announced funding. Thus continuing to go alone with this lead pharma product. Thus while waiting for solid revenues to roll in in approx 12 months to continue self funding Oxypatch.

Therefore I expect Oxypatch project to take longer to complete. But I beleive that strategy is fine as it keeps it completly PoHs until a marketing and distribution partner is required.

Although there is sceptisim here I beleive Harry and Esra are ahead of the game and their strategy is playing out.